ANL
Adlai Nortye Ltd.NASDAQStock$14.37-0.13 (-0.89%)Mkt Cap 762.8MP/E —Div Yield —Beta -1.45Vol 15.6KAvg Vol 136.4K
52W$0.88
$16.60
ETFs That Hold ANL (Adlai Nortye Ltd.)
1M
-7.35%
3M
+34.55%
6M
+28.65%
YTD
+941.30%
1Y
+730.64%
3Y
+36.73%
5Y
-4.20%
ETFs That Hold ANL
Adlai Nortye Ltd. is held by 3 ETFs. The largest position by market value is in CANC (Tema Oncology ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| CANC | Tema Oncology ETF | 0.58% |
| BBC | Virtus Biotech Clinical Trials ETF | 1.14% |
| GXC | State Street SPDR S&P China ETF | 0.02% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold ANL?
Adlai Nortye Ltd. (ANL) is held by 3 ETFs (excluding leveraged and inverse funds). The largest position by market value is in CANC (Tema Oncology ETF).
What is the largest ETF that holds ANL?
By fund size, CANC (Tema Oncology ETF) with $205.3M in AUM holds 0.58% of its portfolio in ANL, representing $1.2M in market value.
What percentage of BBC is ANL?
ANL makes up 1.14% of BBC (Virtus Biotech Clinical Trials ETF), making it one of the largest positions in that fund.
Is ANL in the S&P 500?
ANL is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.